Johnson & Johnson announced Monday that it has agreed to pay $5.5 billion to put to rest tens of thousands of lawsuits alleging its talcum powder products caused ovarian cancer, with plaintiffs' counsel calling the deal "long-delayed justice" for their clients.
Johnson & Johnson announced Monday that it has agreed to pay $5.5 billion to put to rest tens of thousands of lawsuits alleging its talcum powder products caused ovarian cancer, with plaintiffs' counsel calling the deal "long-delayed justice" for their clients.
A New Jersey state court on Monday entered a $25.4 million judgment against Cooley LLP after a jury found the multinational firm had committed malpractice in its representation of a biotech founder who said his own lawyers assisted in shoving him out of his company.
A New Jersey judge on Monday recommended sending the state attorney general's lawsuit alleging Sig Sauer Inc. deceptively marketed its P320 handgun back to state court, concluding the firearms-maker failed to establish that the case belonged in federal court.
The New Jersey Supreme Court on Monday set forth parameters for third-party legal fee arrangements in criminal cases, upholding a murder conviction on the grounds that no conflict of interest resulted from a state witness paying his lawyer and finding that third‑party payments don't create per se conflicts of interest.
AbbVie Inc. and collaborator Ironwood Pharmaceuticals urged a New Jersey federal court to bar India-based generic-drug maker Alkem Laboratories from selling generic versions of their branded constipation drug while associated patents are active, arguing Alkem would violate patent law by doing so.
Newark, New Jersey, Mayor Ras Baraka is pushing back on a bid from the U.S. Department of Justice to dismiss a lawsuit over his allegedly unlawful arrest last year outside an ICE facility, telling a New Jersey federal court that the government's theories of immunity don't fit the facts and case law.
The Trump administration has asked the U.S. Supreme Court to step in after the First Circuit declined on Saturday to lift a lower court's order prohibiting the administration from enforcing restrictions on mail-in balloting in 23 states and the District of Columbia in this year's general election.
The U.S. Department of Justice has joined with Live Nation to resist a discovery request by a bipartisan group of state attorneys general seeking more information about a settlement the federal government reached with the company in the middle of an antitrust trial.
Courts' recent endorsement of the involvement-of-counsel defense in securities fraud litigation has clarified that its use depends on how evidence is used, carrying important lessons for presenting evidence of a disclosure process to undermine scienter, say attorneys at Sidley.
U.S. District Judge Alan Albright of the Western District of Texas examines how artificial intelligence could transform a court's ability to deal with administrative work and organize materials when preparing for hearings or drafting opinions, thereby affording judges more time to resolve contested issues.
Milbank LLP is continuing to lead the way on bonuses, confirming Monday it has issued a round of special bonuses ranging from $6,000 for the class of 2026 and 2025 associates to $25,000 for the class of 2021 associates and beyond.
The American Bar Association on Monday urged the D.C. federal judge overseeing its lawsuit challenging 2025 executive orders targeting law firms to reject the Trump administration's bid to have Susman Godfrey LLP disqualified as plaintiffs' counsel, calling it the latest "effort to intimidate" the American legal profession.
A California federal judge Monday approved a court-ordered ethics training program prepared by Quinn Emanuel in the wake of misrepresentations the firm made concerning an expert in a false advertising suit brought by Guardant Health against its client Natera, saying the firm had designed an "extremely promising" eight-hour program.
A Simpson Thacher & Bartlett LLP partner wrapped up her testimony Monday in a Florida state malpractice trial brought by the founder of Patriot National Inc., telling the jury that the founder was willing to forgo establishing a floor on the value of so-called Series B warrants, which he says contributed to the company's demise.
Former FBI Director James Comey urged a North Carolina federal court Monday to dismiss an indictment stemming from a social media post he made last year, arguing the post doesn't constitute a "true threat" to President Donald Trump.
